<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> demonstrates an increase in activated oxygen species in the brain that could lead to eventual neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Neuronal cells respond to oxygen free radicals through the restructuring of the cytoskeleton and membranes, mobilization of calcium and gene expression which play a role in cell injury </plain></SENT>
<SENT sid="2" pm="."><plain>Ten min of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> resulted in a decrease in calcium/calmodulin dependent protein kinase II (CaM kinase II) phosphorylation and activity detected in the brain immediately following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and was partially restored within 24 h of reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Pretreatment of animals with an <z:chebi fb="164" ids="38867">anesthetic</z:chebi> dose of <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> (40 mg/kg) resulted in partial protection of inactivation of CaM kinase II following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>CaM kinase II activity was maintained following pretreatment of animals with alpha-<z:chebi fb="1" ids="30396">phenyl</z:chebi> N-<z:chebi fb="0" ids="30355">tert-butyl</z:chebi> nitrone (PBN), which traps oxygen free radicals </plain></SENT>
<SENT sid="5" pm="."><plain>Infusion of <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase or catalase prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, blocked CaM kinase II inactivation </plain></SENT>
<SENT sid="6" pm="."><plain>Blockage of calcium uptake with <z:chebi fb="0" ids="3061">bepridil</z:chebi> resulted in a marked protection of CaM kinase II inactivation </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, <z:chebi fb="0" ids="45951">trifluoperazine</z:chebi>, a calmodulin <z:chebi fb="68" ids="48706">antagonist</z:chebi> also diminished the inhibition of CaM kinase II phosphorylation in our model </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion injury results in the generation of activated oxygen and the mobilization of calcium which inactivate CaM kinase II </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that changes associated with protein kinase activity in the brain following an ischemic insult may have profound effects upon <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> and neuronal survival </plain></SENT>
</text></document>